ARCHIVES

Degarelix Active In Phase II Trial In Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

Hudis’s Address At ASCO 2014: On Value & Commitment

June 6, 2014

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

ASCO, ASH Issue Guidelines On Use Of Epo For Anemia

October 25, 2002

Advisory Council To Be Named For Alternative Medicine Cuts

May 27, 1994